These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1764295)

  • 21. Statistics review 11: assessing risk.
    Bewick V; Cheek L; Ball J
    Crit Care; 2004 Aug; 8(4):287-91. PubMed ID: 15312212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Calculation of sample size for the detection of relative risk with a predetermined confidence level and power].
    Bernard PM; Lapointe C
    Rev Epidemiol Sante Publique; 1990; 38(3):255-60. PubMed ID: 2396039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative risks and odds ratios: what's the difference?
    Last A; Wilson S
    J Fam Pract; 2004 Feb; 53(2):108. PubMed ID: 14764292
    [No Abstract]   [Full Text] [Related]  

  • 24. Sequential monitoring of clinical trials with multiple survival endpoints.
    Williams PL
    Stat Med; 1996 Nov 15-30; 15(21-22):2341-57; discussion 2367-70. PubMed ID: 8931205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect-size measures and research in developmental and behavioral pediatrics.
    Colliver JA
    J Dev Behav Pediatr; 2007 Apr; 28(2):145-50. PubMed ID: 17435467
    [No Abstract]   [Full Text] [Related]  

  • 26. [Correlation measures in epidemiology].
    Ollivier L; Michel R; Spiegel A; Boutin JP
    Med Trop (Mars); 2003; 63(1):75-8. PubMed ID: 12891755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statistical tools in the quest for truth: hypothesis testing, confidence intervals, and the power of clinical studies.
    Smith SD
    Ophthalmology; 2008 Mar; 115(3):423-4. PubMed ID: 18319103
    [No Abstract]   [Full Text] [Related]  

  • 28. Statistical inference from qualitative data: proportions, relative risks and odds ratios.
    Indrayan A; Satyanarayana L
    Indian Pediatr; 2000 Sep; 37(9):967-81. PubMed ID: 10992333
    [No Abstract]   [Full Text] [Related]  

  • 29. Are we satisfied with the way we review an article?
    Aslam M; Burris HH; Zupancic JA
    Adv Neonatal Care; 2009 Feb; 9(1):40-2. PubMed ID: 19212165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of the SCORE and Wilson-Grundy methods for the assessment of cardiovascular risk in community pharmacies.
    Amariles P; Machuca M; Faus MJ; Baena MI; Martinez-Martinez F; Jimenez-Martin J
    J Clin Pharm Ther; 2008 Oct; 33(5):475-81. PubMed ID: 18834361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Notes regarding confidence intervals and statistics for standardized mortality ratios and survival curves in the insurance industry.
    Winsemius DK
    J Insur Med; 2006; 38(1):9-13. PubMed ID: 16642638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of conditional and marginal odds-ratios for analysing familial aggregation of binary data.
    FitzGerald PE; Knuiman MW
    Genet Epidemiol; 2000 Mar; 18(3):193-202. PubMed ID: 10723105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Confidence intervals for proportions--the Cinderella of statistical analyses.
    Newcombe RG
    Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):92-3. PubMed ID: 17931844
    [No Abstract]   [Full Text] [Related]  

  • 34. Unconditional efficient one-sided confidence limits for the odds ratio based on conditional likelihood.
    Lloyd CJ; Moldovan MV
    Stat Med; 2007 Dec; 26(28):5136-46. PubMed ID: 17437251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relative merits of risk ratios and odds ratios.
    Cummings P
    Arch Pediatr Adolesc Med; 2009 May; 163(5):438-45. PubMed ID: 19414690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alcohol dehydrogenase 3 genotype is not associated with risk of squamous cell carcinoma of the oral cavity and pharynx.
    Sturgis EM; Dahlstrom KR; Guan Y; Eicher SA; Strom SS; Spitz MR; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):273-5. PubMed ID: 11303599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect measures and confidence intervals].
    Aursnes I
    Tidsskr Nor Laegeforen; 1991 Aug; 111(19):2440-2. PubMed ID: 1926086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Confidence limits vs power, calculations.
    Goodman SN
    Epidemiology; 1994 Mar; 5(2):266-8; author reply 268-9. PubMed ID: 8173006
    [No Abstract]   [Full Text] [Related]  

  • 39. On a supplemented case-control design.
    Pfeiffer RM; Chatterjee N
    Biometrics; 2005 Jun; 61(2):584-90. PubMed ID: 16011708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Confidence intervals, P values, and statistical significance.
    Sedgwick P
    BMJ; 2015 Feb; 350():h1113. PubMed ID: 25724837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.